medication adherence

By Heather Mack 05:09 pm November 10, 2016
Medication adherence device maker PillDrill has secured $3 million in funding for its flagship product, also called PillDrill, and will be featured on the Consumer Technology Association’s website. The device, which launched in April, consists of a compact scanning system called the PillDrillHub that is designed to sit next to the user’s pills. When doses are due, it sends out audio-visual alerts...
By Heather Mack 01:57 pm October 3, 2016
New York City based-startup Quio, which is working on a sensor-enabled drug injector and companion software for the clinical trial and chronic disease market, has raised $1.05 million in seed funding. The undisclosed investors include those with expertise in health insurance, pharmaceuticals and clinical research, the company revealed. Quio is developing Smartinjector, a connected medication...
By Jonah Comstock 03:27 pm September 12, 2016
Today Walgreens shared new data from two studies that show the company's mobile tools -- both its mobile pill reminder and its Balance Rewards for Healthy Choices platform -- improve medication adherence for users.  “People increasingly want to become more engaged in their own health care, and with Walgreens digital health offerings, we give our customers the ability to positively impact their...
By Jonah Comstock 04:03 pm August 22, 2016
Proteus Digital Health is working with Children's Health in Dallas, Texas in one of the first trials of its ingestible sensor technology in pediatric patients, The Dallas Morning News reports. The trial involves patients recovering from an organ transplant, a group that typically needs to take a lot of medications on a fairly strict schedule. Fifteen patients are using the Proteus platform now...
By Heather Mack 02:12 pm August 16, 2016
Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary disease (COPD). The proposed yearlong trial – which is still not yet recruiting participants – will be an intervention study involving an estimated 380 people with COPD divided into two groups. Both...
By Jonah Comstock 03:31 pm August 8, 2016
MedMinder, a Needham, Massachusetts-based company that makes cellular-connected smart pill cases, has raised an additional $500,000 from an undisclosed investor. A longtime player in the connected pillbox space, MedMinder has only raised about $2.3 million in funding to date, all of it from undisclosed private investors. The new funding will be used to support the company's recent expansion into...
By Heather Mack 11:00 am June 28, 2016
HealthPrize Technologies closed a series B round of financing, which included new and existing investors. The medication adherence company intends to use the funds to expand the team both internally and internationally. While the amount of this round remains undisclosed, the company had previously raised about $7 million from investors including Mansa Capital, dLife Founder Howard Steinberg and...
By Jonah Comstock 04:02 pm June 16, 2016
Global pharmaceutical company AstraZeneca has launched a new patient-facing mobile app that includes a virtual savings card, a prescription tracker, and educational materials. The app, available in the US on the iOS App Store and Google Play store, is called AZhelps. “AstraZeneca is committed to providing affordable medicines and programs that help patients get the support they need," Lori...
By Jonah Comstock 02:58 pm May 2, 2016
Boston's Brigham and Women’s Hospital, in partnership with Evidation Health, will test Medisafe’s medication adherence app in a randomized control trial of 390 patients taking medication for high blood pressure. Patients will be monitored with an at-home Bluetooth blood pressure cuff. “I see patients in an acute care setting and there’s a hope that the technology will help people but it’s unclear...
By Jonah Comstock 02:42 pm April 21, 2016
HealthPrize, a Norwalk, Connecticut-based medication adherence platform company, released data this week demonstrating a 99 percent reduction in “gap days” — days between running out of a medication and filling that medication — in patients using its program.  The data comes from a cohort of 1,085 patients taking a branded cholesterol-lowering medication (HealthPrize wasn’t able to disclose which...